Business Context and Reporting Period
Company: Chemed Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: January 18, 2013
Event: Entry into a Material Definitive Agreement regarding a new senior secured credit facility.
Key Financial Metrics
This filing details the terms of a new credit facility rather than reporting operational financial results (revenue, profit, or cash flow).
- Revolving Credit Facility: $350 million
- Expansion Feature: $150 million (available for term loans or additional revolving commitments)
- Maturity: 5 years
- Interest Rate Structure: Floating rate (LIBOR plus a margin based on leverage ratio)
- Inception Interest Rate: LIBOR plus 1.25%
- Repayment Terms: Principal payments due at maturity; interest payable quarterly
Material Changes
The company replaced its existing credit facility with a new Second Amended and Restated Credit Agreement. This change increases the available revolving credit to $350 million and adds a $150 million expansion option, providing enhanced liquidity flexibility compared to the prior arrangement.
Outlook, Risks, and Management Commentary
Management Commentary: The agreement was executed with JPMorgan Chase Bank, N.A. (administrative agent), Bank of America, N.A. (syndication agent), and U.S. Bank National Association (documentation agent).
Risks/Contingencies: The interest rate is variable and tied to the company's leverage ratio, meaning borrowing costs will fluctuate based on market indexes and the company's financial position. The filing does not disclose specific risks beyond the standard terms of the credit agreement.
Investor Verification Checklist
- Verify the specific leverage ratio thresholds that determine the interest rate margin.
- Confirm the status of the $150 million expansion feature and any conditions required to activate it.
- Review the full text of the Second Amended and Restated Credit Agreement (Exhibit 10.1) for covenants and restrictions.
- Check subsequent filings for the actual utilization of the new revolving facility.